Cerebral Palsy: cell-therapy evidence by therapy class
Across every stem-cell intervention, ClinicalTrials.gov holds 41 registered records for Cerebral Palsy — 2 recruiting, 2 at Phase 3 or 4, in 16 countries. Snapshot 2026-08-29.
The condition, and why cells are proposed
Cerebral palsy follows a fixed early brain injury; the injury does not progress, but its functional consequences change as a child grows. Cell therapy is studied for neuroplasticity support alongside intensive rehabilitation. Because rehabilitation itself drives measurable gains, separating a cell effect from a therapy effect is the central design problem, and commercial offers almost never try.
Therapy classes side by side
Counts come from separate registry queries per class; a study testing two interventions can appear in more than one row, so rows do not sum to the all-interventions total.
Geography of the research
United States accounts for about 28% of country mentions among sampled studies; 16 countries host at least one site.
| Country | Studies with a site there |
|---|---|
| United States | 10 |
| Mexico | 4 |
| India | 4 |
| South Korea | 3 |
| Iran | 3 |
| China | 3 |
| Vietnam | 3 |
| United Arab Emirates | 2 |
The largest registered studies
Sorted by planned enrolment — size is not quality, but a 300-participant trial can answer questions a 12-participant series cannot.
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT02795052 — Neurologic Stem Cell Treatment Study | n/a | Recruiting | 500 | MD Stem Cells | 2016-06 |
| NCT01929434 — Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis | Phase 3 | Completed | 300 | General Hospital of Chinese Armed Police Forces | 2013-10 |
| NCT04098029 — Estimation of the Safety and Efficiency Transfusion of HLA Matched CBU in Patients With CP | Phase 2 | Unknown | 150 | State-Financed Health Facility "Samara Regional Medical Cent | 2019-09-01 |
| NCT03795974 — Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy | Phase 2 | Unknown | 108 | Tehran University of Medical Sciences | 2017-07-23 |
| NCT01193660 — Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy | n/a | Completed | 105 | Sung Kwang Medical Foundation | 2010-05 |
| NCT01832454 — Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years | Phase 2, Phase 3 | Unknown | 100 | Chaitanya Hospital, Pune | 2011-03 |
Most recently registered
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT07521384 — Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy | n/a | Enrolling By Invitation | n/a | Healing Hope International | 2026-06-01 |
| NCT05018871 — Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP | n/a | Suspended | n/a | The Foundation for Orthopaedics and Regenerative Medicine | 2025-12 |
| NCT05018819 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP | n/a | Recruiting | n/a | The Foundation for Orthopaedics and Regenerative Medicine | 2022-02-01 |
| NCT04314687 — Stem Cell and Conditioned Medium for Cerebral Palsy | n/a | Active Not Recruiting | n/a | PT. Prodia Stem Cell Indonesia | 2021-10-13 |
| NCT04653077 — MSCs Therapy for Cerebral Palsy | n/a | Unknown | n/a | Aljazeera Hospital | 2020-12-02 |
Reading this honestly
A registry is a plan repository. Counting entries tells you what people intended to study, which is a weaker thing than what they found. For Cerebral Palsy specifically, the practical question is which registered study — if any — matches the product a provider is offering, and what its outcome measures actually are.
Frequently asked
How many stem-cell trials exist for Cerebral Palsy?
41 registered records mention a stem-cell intervention for this condition (2026-08-29 snapshot), of which 2 were recruiting.
Which therapy class is furthest along for Cerebral Palsy?
Ranked by Phase 3/4 records: MSC (1), HSCT (1), exosomes (0), PRP (0).
Does a recruiting trial mean I can be treated?
No. Trials have eligibility criteria, and joining one is not the same as buying a treatment. Paying a clinic for an unproven intervention outside a registered study gives you neither the protections nor the data collection of a trial.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
Download the query data
Query totals are full API matches; status, phase and country counts describe the first up to 400 returned records per query. Query classes overlap and must not be summed as unique trials. Counts are not treatment outcomes. Snapshot: 2026-08-29. Methods and field definitions.